Zimbabwe has rejected a significant American healthcare agreement worth 367 million US dollars (£272m) over five years due to the United States' request for sensitive information.
The decision came to light after a official document dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".
An official representative later clarified that the US was seeking biological samples for research and commercial gain but was not willing to share the benefits from future medical innovations.
"We are forced to start the difficult and regrettable task of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had provided over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for continued negotiations to secure a deal suitable to both sides so the nation's critical HIV treatment initiative can continue.
Wider Context
This development follows a similar situation in neighbouring Kenya, where a court suspended a similar health funding agreement after legal challenges were raised about the safety of citizens' medical information.
Since resuming office last year, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump argued its spending was "inefficient" and his government was seeking government-to-government deals to boost openness and accountability.
According to reports, 16 nations in Africa have to date agreed to similar health pacts, representing over $18.3bn in new funding.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this partnership would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy through US-supported programmes," Tremont said.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its biological resources and data for a long time, without any corresponding promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Effectively, our country would provide the raw materials for medical research with no assurance that the end products would be available to our population if a new health crisis emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were undermining structures already set up through the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage future pandemics.
"This system is intended to guarantee that when a country provides its samples, the benefits – such as medicines and cures – are shared equitably, not commercialised solely by those with the capability to develop them."
The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We are open to further discussions with our American counterparts on how future collaboration might be arranged in a way that respects the sovereignty and interests of each country."
Medical Community Response
A leading public health body stated it understood the government's concerns, but suggested that talks should continue considering a large portion of the nation's Aids initiatives relied on foreign aid.
"If specific concerns exist, including those relating to information security or agreement terms, these can frequently be resolved via technical clarification and negotiated safeguards," the group said.
The situation underscores the ongoing challenges between accepting crucial foreign assistance and protecting a country's data in an increasingly interconnected world.